Viewing nowEnsulim Tablet (Phenmetrazine Tartrate)
Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Joah Pharmaceutical Co., Ltd.

MFDS item code 200210718 · Approved 2002.09.02
Weight loss adjunct therapy for patients with obesity (including risk factors such as hypertension and diabetes)
This medication is used for obese patients who do not respond to appropriate weight loss therapy (diet and exercise therapy). Specifically, it is indicated for patients with an initial Body Mass Index (BMI) of 30 kg/m2 or higher, or, in cases accompanied by risk factors such as hypertension, diabetes, or hyperlipidemia, for those with a BMI of 27 kg/m2 or higher. This medication is used as a short-term adjunct therapy for weight loss treatment in cases of exogenous obesity based on calorie restriction and should be used alone without the combination of other appetite suppressants. The Body Mass Index is calculated by dividing the weight (kg) by the square of height (m), and this medication helps improve health by controlling weight. Therefore, it is used as adjunct therapy for the treatment of obesity.
Adults should take 35 mg of Phenmetrazine Tartrate orally 2 to 3 times per day, 1 hour before meals. The dose should start with the minimum effective dose and be adjusted individually to achieve an appropriate response. For some patients, 17.5 mg once daily may be adequate. The maximum single dose should not exceed 70 mg taken more than 3 times a day. This medication is to be administered for a short period (within 4 weeks). The first four
This medication may cause serious heart disease if used in conjunction with other appetite suppressants, so it must be used alone and only for a short duration. Special caution is advised if taken for more than three months as this significantly increases the risk of a rare heart disease called pulmonary arterial hypertension. It is also advisable to undergo heart examinations before and during treatment with this drug due to the risk of heart valve disease. This medication should not be used by individuals with certain cardiovascular diseases, hyperthyroidism, glaucoma, those in a state of mental unrest, or those with a history of substance abuse. Additionally, it should not be administered to children under 16 years old, pregnant women, or individuals with hereditary lactose intolerance. Individuals with mild hypertension, nursing mothers, and diabetic patients should be particularly cautious; diabetic patients may require insulin dose adjustments. This medication can cause cardiovascular side effects such as rapid heartbeat or increased blood pressure, as well as central nervous system side effects like anxiety, insomnia, and dizziness. In case of excessive dosage, severe symptoms like anxiety, coma, and convulsions may occur; therefore, the prescribed dosage should be strictly adhered to. This medication affects the central nervous system, so caution is required during driving or operating machines, and abrupt fatigue and depression may occur upon discontinuation of use. Keep this medication out of reach of children and use it cautiously due to its classification as a narcotic with potential for dependence and abuse.
Palpitations, tachycardia, increased blood pressure, overstimulation, anxiety, dizziness, insomnia, tremors, euphoria, headache, mental disorders at recommended doses, agitation, flushing, sweating, blurred vision, dry mouth, discomfort, diarrhea, constipation, nausea, abdominal pain, changes in sexual drive, frequent urination, urinary retention, erectile dysfunction, severe skin conditions, insomnia, irritability, hyperfunction, personality changes, and psychotic symptoms similar to schizophrenia.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 °C and 30 °C at room temperature.
White round tablets
30 T/bottle, 300 T/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPhendimetrazine Tartrate 35mg
Tablet · Prescription medication
Joah Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Albuzene Korea Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Bionex Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
PharmGen Science Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Dae Won Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.